Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
- In this demo DXP file, the scientist is analyzing multi-plexed ELISA data obtained from clinical trails Subject's blood samples. By integrating traditional clinical labs data with translational research labs data and clinical therapeutic response assessments, the scientist is able to derive novel insights into the relationship between the amount of drug in the Subject's blood, the degree of biological effect, and clinical response.
Integrating Multiplexed ELISA and Clinical data to drive patient selection
Translational Medicine Overview
Your login attempt was not successful. Please try again.
Setup is fast and easy. Click below to register.
A Flash compatible player was not detected on your system, otherwise you would see videos here. If you can play an mp4, download the video as mp4 here